{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:06:39Z","timestamp":1747713999780,"version":"3.40.5"},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1590\/abd1806-4841.20164292","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T16:12:05Z","timestamp":1468426325000},"page":"306-310","source":"Crossref","is-referenced-by-count":2,"title":["Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients"],"prefix":"10.1590","volume":"91","author":[{"given":"Jo\u00e3o Roberto","family":"Antonio","sequence":"first","affiliation":[{"name":"Faculdade Estadual de Medicina de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil; Hospital de Base de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Sanmiguel","sequence":"additional","affiliation":[{"name":"Faculdade Estadual de Medicina de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana Viotto","family":"Cagnon","sequence":"additional","affiliation":[{"name":"Faculdade Estadual de Medicina de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia Silveira Faeda","family":"Augusto","sequence":"additional","affiliation":[{"name":"Faculdade Estadual de Medicina de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacir Fernandes de","family":"Godoy","sequence":"additional","affiliation":[{"name":"Faculdade Estadual de Medicina de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eurides Maria Oliveira","family":"Pozetti","sequence":"additional","affiliation":[{"name":"Faculdade Estadual de Medicina de S\u00e3o Jos\u00e9 do Rio Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Consenso Brasileiro de Psor\u00edase 2009","first-page":"31","volume-title":"Artrite Psori\u00e1sica e comorbidades","author":"Duarte AA","year":"2009"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","article-title":"Treatments for psoriasis and the risk of malignancy","volume":"60","author":"Patel RV","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref3","first-page":"12","article-title":"Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis","volume":"14","author":"Chan CY","year":"2008","journal-title":"Dermatol Online J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00403-008-0831-8","article-title":"Manifestation of palmoplantarpustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases","volume":"300","author":"M\u00f6ssner R1","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"ref5","first-page":"326","article-title":"Efficacy of infliximab in patients with moderate and severe psoriasis treated with infliximab (Remicade)","volume":"134","author":"Vald\u00e9s A","year":"2006","journal-title":"Rev Med Chil"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab indution and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich K","year":"2005","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712598.6.8.797","article-title":"Infliximab for treatment of psoriasis","volume":"6","author":"Kleyn CE","year":"2006","journal-title":"Expert Opin Biol Ther"},{"year":"2014","series-title":"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects","author":"John H S","key":"ref8"},{"year":"2014","series-title":"Tumor necrosis factor-alpha inhibitors: Risk of bacterial, viral, and fungal infections","author":"John H S","key":"ref9"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.2008.08728.x","article-title":"Review and expert opinion on prevention and treatment of infliximab-related infusion reactions","volume":"159","author":"Lecluse LL","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2004.02.021","article-title":"Infliximabeinditiontherapy for pacients with severe plaque types psoriasis: a randomized doubleblind, placebo-controlled trial","volume":"51","author":"Gottlieb AB","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"ref12","first-page":"250","article-title":"Monoclonal antibodies, immunogenicity, and associated infusion reactions","volume":"72","author":"Cheifetz A","year":"2005","journal-title":"Mt Sinai J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNFblockade therapy: a review and analysis of 127 cases","volume":"20","author":"Ko JM","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1468-3083.2008.02818.x","article-title":"Infliximab-induced pityriasislichenoideschronica in a patient with psoriasis","volume":"23","author":"Newell EL","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref15","first-page":"363","article-title":"Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases","volume":"99","author":"Benucci M","year":"2008","journal-title":"Recenti Prog Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial","volume":"357","author":"Chaudhari U","year":"2001","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty SD","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2036.2003.01411.x","article-title":"Infusion reactions to infliximab in children and adolescents: frequency, autcome and a predictive model","volume":"17","author":"Crandall WV","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"ref19","first-page":"A612","article-title":"Infliximab infusion reactions. The influence of sex and drugs","volume":"122","author":"Han PD","year":"2002","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u00b4s disease","volume":"362","author":"Colombel JF","year":"2010","journal-title":"N Engl J Med"},{"year":"2015","series-title":"Bula REMICADE\u00ae (infliximabe)","key":"ref21"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3899\/jrheum.120649","article-title":"Infusion reactions related to Infliximab therapy are not usually associated with drug discontinuation","volume":"39","author":"Cullen G","year":"2012","journal-title":"J Rheumatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3899\/jrheum.110956","article-title":"Safety of infliximab tratment in patients with rheumatoid arthritis in a real-wold clinical setting: Description and evaluation of infusion reactions","volume":"39","author":"Kelsall J","year":"2012","journal-title":"J Rheumatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v91n3\/0365-0596-abd-91-03-0306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:43Z","timestamp":1747666843000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962016000300306&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0365-05962016000300306"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20164292","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"electronic","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}